These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 23673911

  • 1. Tardive dyskinesia caused by tetrabenazine.
    LeWitt PA.
    Clin Neuropharmacol; 2013; 36(3):92-3. PubMed ID: 23673911
    [Abstract] [Full Text] [Related]

  • 2. Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias.
    Jankovic J, Orman J.
    Neurology; 1988 Mar; 38(3):391-4. PubMed ID: 3279337
    [Abstract] [Full Text] [Related]

  • 3. Tetrabenazine in the treatment of hyperkinetic movement disorders.
    Kenney C, Jankovic J.
    Expert Rev Neurother; 2006 Jan; 6(1):7-17. PubMed ID: 16466307
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Treatment of hyperkinetic movement disorders with tetrabenazine: a double-blind crossover study.
    Jankovic J.
    Ann Neurol; 1982 Jan; 11(1):41-7. PubMed ID: 6460467
    [Abstract] [Full Text] [Related]

  • 9. Tetrabenazine for the treatment of tardive dyskinesia.
    Leung JG, Breden EL.
    Ann Pharmacother; 2011 Apr; 45(4):525-31. PubMed ID: 21487088
    [Abstract] [Full Text] [Related]

  • 10. Tetrabenazine for the treatment of chorea and other hyperkinetic movement disorders.
    Jankovic J, Clarence-Smith K.
    Expert Rev Neurother; 2011 Nov; 11(11):1509-23. PubMed ID: 22014129
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Deuterium Tetrabenazine for Tardive Dyskinesia.
    Cummings MA, Proctor GJ, Stahl SM.
    Clin Schizophr Relat Psychoses; 2018 Jan; 11(4):214-220. PubMed ID: 29341821
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Tetrabenazine and movement disorders.
    Asher SW, Aminoff MJ.
    Neurology; 1981 Aug; 31(8):1051-4. PubMed ID: 6455607
    [Abstract] [Full Text] [Related]

  • 15. [Therapeutic use of tetrabenazine].
    López Del Val LJ, López-García E, Martínez-Martínez L, Santos-Lasaosa S.
    Rev Neurol; 1981 Aug; 48(10):523-33. PubMed ID: 19434587
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Tetrabenazine.
    Fasano A, Bentivoglio AR.
    Expert Opin Pharmacother; 2009 Dec; 10(17):2883-96. PubMed ID: 19929707
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Tetrabenazine, a monoamine-depleting drug used in the treatment of hyperkinetic movement disorders.
    Guay DR.
    Am J Geriatr Pharmacother; 2010 Aug; 8(4):331-73. PubMed ID: 20869622
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.